|
Clinicopathological characteristics
|
CDCA3 expression level
|
Total
|
P value
|
|---|
|
Low
|
High
|
|---|
|
Overall
|
211
|
165
|
376
| |
|
Gender
| | | |
|
Female
|
59 (27.96%)
|
39 (23.64%)
|
98
|
0.3430
|
|
Male
|
152 (72.04%)
|
126 (76.36%)
|
278
|
|
Grade
| | | | |
|
Low
|
17 (8.06%)
|
3 (1.82%)
|
20
|
0.0075**
|
|
High
|
194 (91.94%)
|
162 (98.18%)
|
356
|
|
Stage
| | | | |
|
I + II
|
58 (27.49%)
|
60 (36.36%)
|
118
|
0.0657
|
|
III + IV
|
153 (72.51%)
|
105 (63.64%)
|
258
|
|
T stage
| | | | |
|
T0 + T1 + T2
|
72 (34.12%)
|
50 (30.30%)
|
147
|
0.4324
|
|
T3 + T4
|
139 (65.88%)
|
115 (69.70%)
|
229
|
|
M stage
| | | | |
|
M0
|
110 (52.13%)
|
70 (42.42%)
|
180
|
0.0615
|
|
M1 + MX
|
101 (47.87%)
|
95 (57.58%)
|
196
|
|
N stage
| | | | |
|
N0
|
128 (60.66%)
|
96 (58.18%)
|
224
|
0.6265
|
|
N1 + N2 + NX
|
83 (39.34%)
|
69 (41.82%)
|
152
|
